Autophagy in the immune response to tuberculosis: clinical perspectives

Clin Exp Immunol. 2011 Jun;164(3):291-300. doi: 10.1111/j.1365-2249.2011.04381.x. Epub 2011 Mar 25.

Abstract

A growing body of evidence points to autophagy as an essential component in the immune response to tuberculosis. Autophagy is a direct mechanism of killing intracellular Mycobacterium tuberculosis and also acts as a modulator of proinflammatory cytokine secretion. In addition, autophagy plays a key role in antigen processing and presentation. Autophagy is modulated by cytokines; it is stimulated by T helper type 1 (Th1) cytokines such as tumour necrosis factor (TNF)-α and interferon (IFN)-γ, and is inhibited by the Th2 cytokines interleukin (IL)-4 and IL-13 and the anti-inflammatory cytokine IL-10. Vitamin D, via cathelicidin, can also induce autophagy, as can Toll-like receptor (TLR)-mediated signals. Autophagy-promoting agents, administered either locally to the lungs or systemically, could have a clinical application as adjunctive treatment of drug-resistant and drug-sensitive tuberculosis. Moreover, vaccines which effectively induce autophagy could be more successful in preventing acquisition or reactivation of latent tuberculosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antigen Presentation / drug effects
  • Antitubercular Agents / therapeutic use
  • Autophagy / drug effects
  • Autophagy / immunology
  • Cytokines / immunology*
  • Humans
  • Immunity
  • Mycobacterium tuberculosis / immunology*
  • Th1-Th2 Balance / drug effects
  • Tuberculosis / immunology*
  • Tuberculosis / therapy

Substances

  • Antitubercular Agents
  • Cytokines